CN108813500B - 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 - Google Patents
具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 Download PDFInfo
- Publication number
- CN108813500B CN108813500B CN201810521071.4A CN201810521071A CN108813500B CN 108813500 B CN108813500 B CN 108813500B CN 201810521071 A CN201810521071 A CN 201810521071A CN 108813500 B CN108813500 B CN 108813500B
- Authority
- CN
- China
- Prior art keywords
- honey
- preserving
- health
- filtering
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000012907 honey Nutrition 0.000 title claims abstract description 194
- 210000004369 blood Anatomy 0.000 title abstract description 74
- 239000008280 blood Substances 0.000 title abstract description 74
- 230000006870 function Effects 0.000 title abstract description 38
- 230000001105 regulatory effect Effects 0.000 title abstract description 30
- 210000005036 nerve Anatomy 0.000 title abstract description 13
- 230000000694 effects Effects 0.000 title description 67
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 93
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 93
- 244000179886 Moringa oleifera Species 0.000 claims abstract description 67
- 235000011347 Moringa oleifera Nutrition 0.000 claims abstract description 67
- 108010010803 Gelatin Proteins 0.000 claims abstract description 47
- 239000008273 gelatin Substances 0.000 claims abstract description 47
- 229920000159 gelatin Polymers 0.000 claims abstract description 47
- 235000019322 gelatine Nutrition 0.000 claims abstract description 47
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 47
- 230000036541 health Effects 0.000 claims abstract description 47
- 244000197580 Poria cocos Species 0.000 claims abstract description 34
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 34
- 235000004789 Rosa xanthina Nutrition 0.000 claims abstract description 30
- 241000109329 Rosa xanthina Species 0.000 claims abstract description 29
- 238000001816 cooling Methods 0.000 claims abstract description 15
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 93
- 238000001914 filtration Methods 0.000 claims description 62
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- 238000003756 stirring Methods 0.000 claims description 51
- 239000007788 liquid Substances 0.000 claims description 43
- 238000000034 method Methods 0.000 claims description 26
- 239000002244 precipitate Substances 0.000 claims description 16
- 235000021433 fructose syrup Nutrition 0.000 claims description 15
- 230000002829 reductive effect Effects 0.000 claims description 15
- 235000019534 high fructose corn syrup Nutrition 0.000 claims description 14
- 238000002844 melting Methods 0.000 claims description 11
- 230000008018 melting Effects 0.000 claims description 11
- 238000004321 preservation Methods 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 abstract description 24
- 201000010099 disease Diseases 0.000 abstract description 21
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 21
- 206010028980 Neoplasm Diseases 0.000 abstract description 20
- 230000001737 promoting effect Effects 0.000 abstract description 19
- 230000007812 deficiency Effects 0.000 abstract description 17
- 210000002216 heart Anatomy 0.000 abstract description 17
- 210000004185 liver Anatomy 0.000 abstract description 17
- 230000003405 preventing effect Effects 0.000 abstract description 15
- 230000001603 reducing effect Effects 0.000 abstract description 13
- 230000036039 immunity Effects 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 12
- 206010011224 Cough Diseases 0.000 abstract description 11
- 206010037660 Pyrexia Diseases 0.000 abstract description 10
- 201000011510 cancer Diseases 0.000 abstract description 10
- 210000004027 cell Anatomy 0.000 abstract description 10
- 230000002401 inhibitory effect Effects 0.000 abstract description 9
- 230000002708 enhancing effect Effects 0.000 abstract description 8
- 206010000234 Abortion spontaneous Diseases 0.000 abstract description 7
- 208000034507 Haematemesis Diseases 0.000 abstract description 7
- 206010061218 Inflammation Diseases 0.000 abstract description 7
- 230000004054 inflammatory process Effects 0.000 abstract description 7
- 208000015994 miscarriage Diseases 0.000 abstract description 7
- 208000000995 spontaneous abortion Diseases 0.000 abstract description 7
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 231100000331 toxic Toxicity 0.000 abstract description 6
- 230000002588 toxic effect Effects 0.000 abstract description 6
- 241000894006 Bacteria Species 0.000 abstract description 5
- 208000037093 Menstruation Disturbances Diseases 0.000 abstract description 5
- 206010027339 Menstruation irregular Diseases 0.000 abstract description 5
- 208000001780 epistaxis Diseases 0.000 abstract description 5
- 208000035861 hematochezia Diseases 0.000 abstract description 5
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 abstract description 4
- 208000032843 Hemorrhage Diseases 0.000 abstract description 4
- 230000000740 bleeding effect Effects 0.000 abstract description 4
- 230000003467 diminishing effect Effects 0.000 abstract description 4
- 230000035935 pregnancy Effects 0.000 abstract description 4
- 230000017423 tissue regeneration Effects 0.000 abstract description 4
- 230000009084 cardiovascular function Effects 0.000 abstract description 2
- 210000003494 hepatocyte Anatomy 0.000 abstract 1
- 230000009758 senescence Effects 0.000 abstract 1
- 241001570521 Lonicera periclymenum Species 0.000 description 90
- 239000003814 drug Substances 0.000 description 29
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 28
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 27
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 27
- 229940074393 chlorogenic acid Drugs 0.000 description 27
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 27
- 235000001368 chlorogenic acid Nutrition 0.000 description 27
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 27
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 27
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 26
- 210000000952 spleen Anatomy 0.000 description 25
- 235000013305 food Nutrition 0.000 description 20
- 238000012360 testing method Methods 0.000 description 20
- 208000002193 Pain Diseases 0.000 description 19
- 210000002784 stomach Anatomy 0.000 description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 18
- 239000000306 component Substances 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 241000628997 Flos Species 0.000 description 17
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 16
- 239000011575 calcium Substances 0.000 description 16
- 229910052791 calcium Inorganic materials 0.000 description 16
- 230000009471 action Effects 0.000 description 15
- 208000001848 dysentery Diseases 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 14
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 13
- 229910052742 iron Inorganic materials 0.000 description 13
- 241000196324 Embryophyta Species 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 239000003925 fat Substances 0.000 description 12
- 235000019197 fats Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 108090000623 proteins and genes Proteins 0.000 description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 11
- 239000008103 glucose Substances 0.000 description 11
- 210000004072 lung Anatomy 0.000 description 11
- 235000019640 taste Nutrition 0.000 description 11
- 206010007247 Carbuncle Diseases 0.000 description 10
- 206010012735 Diarrhoea Diseases 0.000 description 10
- 229930091371 Fructose Natural products 0.000 description 10
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 10
- 238000001035 drying Methods 0.000 description 10
- 229960002737 fructose Drugs 0.000 description 10
- 239000000203 mixture Substances 0.000 description 10
- 206010033557 Palpitations Diseases 0.000 description 9
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 9
- 241000220317 Rosa Species 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 238000005728 strengthening Methods 0.000 description 9
- 230000008961 swelling Effects 0.000 description 9
- 229940088594 vitamin Drugs 0.000 description 9
- 229930003231 vitamin Natural products 0.000 description 9
- 235000013343 vitamin Nutrition 0.000 description 9
- 239000011782 vitamin Substances 0.000 description 9
- 239000005715 Fructose Substances 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 8
- 235000001014 amino acid Nutrition 0.000 description 8
- 150000001413 amino acids Chemical class 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 8
- 235000012000 cholesterol Nutrition 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 206010022437 insomnia Diseases 0.000 description 8
- 239000002398 materia medica Substances 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 241000700159 Rattus Species 0.000 description 7
- 229930003268 Vitamin C Natural products 0.000 description 7
- 229930003427 Vitamin E Natural products 0.000 description 7
- 206010003549 asthenia Diseases 0.000 description 7
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 7
- 239000000284 extract Substances 0.000 description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 7
- 230000000968 intestinal effect Effects 0.000 description 7
- 238000001556 precipitation Methods 0.000 description 7
- 230000002040 relaxant effect Effects 0.000 description 7
- 238000011160 research Methods 0.000 description 7
- 231100000419 toxicity Toxicity 0.000 description 7
- 230000001988 toxicity Effects 0.000 description 7
- 230000002936 tranquilizing effect Effects 0.000 description 7
- 235000019154 vitamin C Nutrition 0.000 description 7
- 239000011718 vitamin C Substances 0.000 description 7
- 239000011709 vitamin E Substances 0.000 description 7
- 235000019165 vitamin E Nutrition 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 206010018910 Haemolysis Diseases 0.000 description 6
- 206010027514 Metrorrhagia Diseases 0.000 description 6
- 241000699670 Mus sp. Species 0.000 description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 208000007502 anemia Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000008588 hemolysis Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 239000011591 potassium Substances 0.000 description 6
- 229910052700 potassium Inorganic materials 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 229940046009 vitamin E Drugs 0.000 description 6
- 208000000044 Amnesia Diseases 0.000 description 5
- 208000031091 Amnestic disease Diseases 0.000 description 5
- 208000015220 Febrile disease Diseases 0.000 description 5
- 206010017553 Furuncle Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000006986 amnesia Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000001939 inductive effect Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000035922 thirst Effects 0.000 description 5
- 238000005303 weighing Methods 0.000 description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 4
- 241000282461 Canis lupus Species 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 4
- 208000005392 Spasm Diseases 0.000 description 4
- 244000269722 Thea sinensis Species 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 4
- 240000008866 Ziziphus nummularia Species 0.000 description 4
- 230000032683 aging Effects 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000001754 anti-pyretic effect Effects 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- 210000004204 blood vessel Anatomy 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000002158 endotoxin Substances 0.000 description 4
- 230000003203 everyday effect Effects 0.000 description 4
- 230000001605 fetal effect Effects 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 150000002772 monosaccharides Chemical class 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000010025 steaming Methods 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000013589 supplement Substances 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 229940045997 vitamin a Drugs 0.000 description 4
- 208000004998 Abdominal Pain Diseases 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000282472 Canis lupus familiaris Species 0.000 description 3
- 206010007882 Cellulitis Diseases 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 102000001554 Hemoglobins Human genes 0.000 description 3
- 108010054147 Hemoglobins Proteins 0.000 description 3
- 241000257303 Hymenoptera Species 0.000 description 3
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 244000167230 Lonicera japonica Species 0.000 description 3
- 235000017617 Lonicera japonica Nutrition 0.000 description 3
- 208000008589 Obesity Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 229930182555 Penicillin Natural products 0.000 description 3
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000033809 Suppuration Diseases 0.000 description 3
- 206010053615 Thermal burn Diseases 0.000 description 3
- 229930003270 Vitamin B Natural products 0.000 description 3
- 210000000683 abdominal cavity Anatomy 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000007815 allergy Effects 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000001914 calming effect Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 210000000038 chest Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 108010052008 colla corii asini Proteins 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000002425 crystallisation Methods 0.000 description 3
- 230000008025 crystallization Effects 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 208000028659 discharge Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 230000002949 hemolytic effect Effects 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000027939 micturition Effects 0.000 description 3
- 229960003512 nicotinic acid Drugs 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 239000011664 nicotinic acid Substances 0.000 description 3
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 3
- 235000020824 obesity Nutrition 0.000 description 3
- 229940049954 penicillin Drugs 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 229960002477 riboflavin Drugs 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 230000001502 supplementing effect Effects 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000002435 tendon Anatomy 0.000 description 3
- 239000012085 test solution Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- PJVXUVWGSCCGHT-ZPYZYFCMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO PJVXUVWGSCCGHT-ZPYZYFCMSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 206010002482 Angiosclerosis Diseases 0.000 description 2
- 241000256844 Apis mellifera Species 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 241000283074 Equus asinus Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010016807 Fluid retention Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 238000012404 In vitro experiment Methods 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 102000004316 Oxidoreductases Human genes 0.000 description 2
- 108090000854 Oxidoreductases Proteins 0.000 description 2
- 206010034038 Parotitis Diseases 0.000 description 2
- 235000001188 Peltandra virginica Nutrition 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 206010035664 Pneumonia Diseases 0.000 description 2
- 208000028872 Progressive muscular dystrophy Diseases 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 240000006066 Rosa rugosa Species 0.000 description 2
- 235000000659 Rosa rugosa Nutrition 0.000 description 2
- 102000007562 Serum Albumin Human genes 0.000 description 2
- 108010071390 Serum Albumin Proteins 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 235000011941 Tilia x europaea Nutrition 0.000 description 2
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 2
- 206010046814 Uterine prolapse Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 241001247821 Ziziphus Species 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 230000004071 biological effect Effects 0.000 description 2
- 229960002685 biotin Drugs 0.000 description 2
- 235000020958 biotin Nutrition 0.000 description 2
- 239000011616 biotin Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 201000001883 cholelithiasis Diseases 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 210000003754 fetus Anatomy 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229960000304 folic acid Drugs 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 208000001130 gallstones Diseases 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000031891 intestinal absorption Effects 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000000265 leukocyte Anatomy 0.000 description 2
- 239000004571 lime Substances 0.000 description 2
- 235000011477 liquorice Nutrition 0.000 description 2
- 210000005229 liver cell Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 208000004396 mastitis Diseases 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000005906 menstruation Effects 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000006180 nutrition needs Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000000242 pagocytic effect Effects 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 201000005404 rubella Diseases 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 239000011593 sulfur Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 1
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 206010000084 Abdominal pain lower Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 241000572565 Alpinia oxyphylla Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 235000019737 Animal fat Nutrition 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 241001164374 Calyx Species 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008342 Cervix carcinoma Diseases 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000000094 Chronic Pain Diseases 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 244000168525 Croton tiglium Species 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 241000427324 Glinus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 208000036581 Haemorrhagic anaemia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000334160 Isatis Species 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 241000239218 Limulus Species 0.000 description 1
- 241000245240 Lonicera Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 229910052765 Lutetium Inorganic materials 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000006662 Mastodynia Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 240000000233 Melia azedarach Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 206010029400 Nicotinic acid deficiency Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 241000227425 Pieris rapae crucivora Species 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 206010036595 Premature delivery Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000081426 Ranunculus ficaria Species 0.000 description 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241001093760 Sapindaceae Species 0.000 description 1
- 208000006268 Sarcoma 180 Diseases 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 208000028990 Skin injury Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 241001327268 Sorghastrum Species 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 240000001949 Taraxacum officinale Species 0.000 description 1
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 206010044541 Traumatic shock Diseases 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
- 241000607626 Vibrio cholerae Species 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- UNLRVSBRNJYNHN-UHFFFAOYSA-N [cyano-(3-phenoxyphenyl)methyl] 2-(4-chlorophenyl)-3-methylbutanoate;dimethoxy-(4-nitrophenoxy)-sulfanylidene-$l^{5}-phosphane Chemical compound COP(=S)(OC)OC1=CC=C([N+]([O-])=O)C=C1.C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 UNLRVSBRNJYNHN-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 210000003489 abdominal muscle Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001986 anti-endotoxic effect Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001775 anti-pathogenic effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003190 augmentative effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 208000027503 bloody stool Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 150000001669 calcium Chemical class 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 230000003913 calcium metabolism Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 201000010881 cervical cancer Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- AIUDWMLXCFRVDR-UHFFFAOYSA-N dimethyl 2-(3-ethyl-3-methylpentyl)propanedioate Chemical class CCC(C)(CC)CCC(C(=O)OC)C(=O)OC AIUDWMLXCFRVDR-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 230000000235 effect on cancer Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 235000021209 fruit soup Nutrition 0.000 description 1
- 235000019990 fruit wine Nutrition 0.000 description 1
- 229940093611 fu ling Drugs 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000005176 gastrointestinal motility Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 239000000413 hydrolysate Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000006278 hypochromic anemia Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 238000004898 kneading Methods 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- -1 luteolin glycoside Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000010016 myocardial function Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 229940023462 paste product Drugs 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229940066779 peptones Drugs 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000012088 reference solution Substances 0.000 description 1
- 239000013558 reference substance Substances 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000010666 rose oil Substances 0.000 description 1
- 235000019719 rose oil Nutrition 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000009210 therapy by ultrasound Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940118696 vibrio cholerae Drugs 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000008530 yinqiaosan Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L21/00—Marmalades, jams, jellies or the like; Products from apiculture; Preparation or treatment thereof
- A23L21/20—Products from apiculture, e.g. royal jelly or pollen; Substitutes therefor
- A23L21/25—Honey; Honey substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及具有补中益气、养血安神和调节人体机能的养生蜂蜜膏。所述养生蜂蜜膏由包括如下的组分制备得到的:蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花。还涉及该养生蜂蜜膏的制备方法,以及其在制备补中益气、养血安神和调节人体机能的产品中的用途,例如在制备改善心血管功能、促进肝细胞再生、抗菌消炎、促进组织再生、增强肠蠕动、提高免疫力、抑制癌细胞、降脂护心、延缓衰老的产品中的用途,例如在制备清热解毒、凉血化淤、增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血、补血、安胎、治血虚、虚劳咳嗽、吐血、衄血、便血、妇女月经不调等的产品中的用途。
Description
技术领域
本发明属于医药健康产品领域,涉及一种蜂蜜膏,特别是涉及一种养生蜂蜜膏,这种养生蜂蜜膏具有补中益气、养血安神和调节人体机能的功效。更特别地是涉及一种由蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花制成的具有补中益气、养血安神和调节人体机能的养生蜂蜜膏,该养生蜂蜜膏具有优异的生物学功能特别是治疗、预防和保健功能,具有清除自由基、抗氧化、抗血栓、抗肿瘤、消炎等多种特殊功效。本发明还涉及所述蜂蜜膏的制备方法,以及这些蜂蜜膏的医药用途。
背景技术
蜂蜜是蜜蜂采集植物花蜜酿成的一种理想的天然保健品。蜂蜜膏是以蜂蜜为主要原料并配以其他食用和药用原料而制备的一种适用于各类人群食用的保健食品。随着人们生活水平的提高以及生活节奏的加快,不同的人群多会表现出不同的亚健康的状态,例如便秘、肤质下降、高血压、骨质增生等,同时也正因为生活水平的提高,人们也更加重视身体健康,并且为了减少药物而带来的副作用开始选择保健类食品去维护身体健康。蜂蜜膏因便于食用且适用于各类人群,开始被越来多的人群所选择,而由于不同人群对于蜂蜜膏的功能往往会有所差异,因此为满足市场需求而需要针对人们的不同需求而生产相应功效的蜂蜜膏。
蜂蜜是蜜蜂采集植物花蜜酿成的天然保健品,其中包含:葡萄糖、果糖、酸类、酶类、维生素、矿物质、蛋白质、芳香物质以及少量的色素、花粉、糖醇类、丹宁类、树脂等其它生物活性物质。其中,葡萄糖和果糖在蜂蜜中占65%以上而赋予蜂蜜的甜味、吸湿性和能量的价值及有形的特征;维生素主要来自蜂蜜中的花粉,并且以B族维生素最为丰富次是维生素C。常见的维生素有核黄素、吡多酸(VB6)、烟酸、叶酸、抗坏血酸、生物素、生育酚等;蜂蜜中的矿物质含量和种类与人体血液中的含量、种类十分相近易于人体吸收。
我国医学经典著作《神农本草经》中把蜂蜜列为药中之上品。中医认为蜂蜜性平味甘,入肺、脾、大肠经,具有滑肠通便、入肺补中、缓急、解毒之功效。《本草纲目》称:“蜂蜜入药之功有五:清热也;补中也;润燥也;解毒也;止痛也。生则性凉,故能解热;熟则性温,故能补中;甘而平和,故能解毒;柔而濡津,故能润燥;缓可以去急,故能止心腹肌肉疮疡之痛;和可至中,故能调和百药,而与甘草同功。蜂蜜在长时间的食用和药用过程中,根据实践人们发现蜂蜜对不同亚健康状态的人群均会起到不同程度的缓急止痛、润肺止咳、润肠通便、润肤生肌、解毒等作用。
然而,本领域仍然需要提供一种养生蜂蜜膏特别是具有补中益气、养血安神和调节人体机能的养生蜂蜜膏。
发明内容
本发明的目的在于提供一种养生蜂蜜膏特别是具有补中益气、养血安神和调节人体机能的养生蜂蜜膏。本发明另一目的在于提供一种制备养生蜂蜜膏特别是具有补中益气、养血安神和调节人体机能的养生蜂蜜膏的方法。已经出人意料的发现,具有本发明配方的养生蜂蜜膏呈现优异的生物学效应,并且本发明制备方法具有优异的膏剂配制效果。
为此,本发明第一方面提供了一种具有补中益气、养血安神和调节人体机能的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,干制红枣的量为50~200克,例如50~150克,例如100克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,茯苓的量为20~100克,例如20~50克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,龙眼肉的量为20~100克,例如20~50克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,金银花的量为20~100克,例如20~50克,例如30克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,阿胶的量为5~30克,例如5~20克,例如10克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,辣木叶的量为50~500克,例如100~200克,例如150克。
根据本发明第一方面的养生蜂蜜膏,以每100克蜂蜜计,玫瑰花的量为50~500克,例如100~250克,例如150克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、干制红枣50~200克、茯苓20~100克、龙眼肉20~100克、金银花20~100克、阿胶5~30克、辣木叶50~500克、玫瑰花50~500克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、干制红枣50~150克、茯苓20~50克、龙眼肉20~50克、金银花20~50克、阿胶5~20克、辣木叶100~200克、玫瑰花100~250克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下的组分制备得到的:蜂蜜100克、干制红枣100克、茯苓30克、龙眼肉30克、金银花30克、阿胶10克、辣木叶150克、玫瑰花150克。
根据本发明第一方面的养生蜂蜜膏,其中还包括果葡糖浆。在一个实施方案中,以每100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
根据本发明第一方面的养生蜂蜜膏,其是由包括如下步骤的方法制备得到的:
(1)将干制红枣、茯苓、龙眼肉用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30~40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55~65%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。已经出人意料的发现,在醇沉时加入果葡萄糖浆不但能够更加有效地除去杂质(步骤(3)两次醇沉后去除的沉淀物量更多),而且能够最高程度地保持有效成分(绿原酸收获率高),这是现有技术根本未曾教导的。
进一步的,本发明第二方面提供了一种制备具有补中益气、养血安神和调节人体机能的养生蜂蜜膏的方法,该方法包括如下步骤:
(1)将干制红枣、茯苓、龙眼肉用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30~40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55~65%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
根据本发明第二方面的方法,以每100克蜂蜜计,干制红枣的量为50~200克,例如50~150克,例如100克。
根据本发明第二方面的方法,以每100克蜂蜜计,茯苓的量为20~100克,例如20~50克,例如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,龙眼肉的量为20~100克,例如20~50克,例如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,金银花的量为20~100克,例如20~50克,例如30克。
根据本发明第二方面的方法,以每100克蜂蜜计,阿胶的量为5~30克,例如5~20克,例如10克。
根据本发明第二方面的方法,以每100克蜂蜜计,辣木叶的量为50~500克,例如100~200克,例如150克。
根据本发明第二方面的方法,以每100克蜂蜜计,玫瑰花的量为50~500克,例如100~250克,例如150克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、干制红枣50~200克、茯苓20~100克、龙眼肉20~100克、金银花20~100克、阿胶5~30克、辣木叶50~500克、玫瑰花50~500克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、干制红枣50~150克、茯苓20~50克、龙眼肉20~50克、金银花20~50克、阿胶5~20克、辣木叶100~200克、玫瑰花100~250克。
根据本发明第二方面的方法,其投料比例为:蜂蜜100克、干制红枣100克、茯苓30克、龙眼肉30克、金银花30克、阿胶10克、辣木叶150克、玫瑰花150克。
根据本发明第二方面的方法,以每100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
进一步的,本发明第三方面涉及养生蜂蜜膏在制备补中益气、养血安神和调节人体机能的产品中的用途。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,干制红枣的量为50~200克,例如50~150克,例如100克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,茯苓的量为20~100克,例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,龙眼肉的量为20~100克,例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,金银花的量为20~100克,例如20~50克,例如30克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,阿胶的量为5~30克,例如5~20克,例如10克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,辣木叶的量为50~500克,例如100~200克,例如150克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏以每100克蜂蜜计,玫瑰花的量为50~500克,例如100~250克,例如150克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、干制红枣50~200克、茯苓20~100克、龙眼肉20~100克、金银花20~100克、阿胶5~30克、辣木叶50~500克、玫瑰花50~500克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、干制红枣50~150克、茯苓20~50克、龙眼肉20~50克、金银花20~50克、阿胶5~20克、辣木叶100~200克、玫瑰花100~250克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下的组分制备得到的:蜂蜜100克、干制红枣100克、茯苓30克、龙眼肉30克、金银花30克、阿胶10克、辣木叶150克、玫瑰花150克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏中还包括果葡糖浆。在一个实施方案中,以每100克蜂蜜计,果葡糖浆的量为5~25克,例如5~20克,例如10克。
根据本发明第三方面的用途,其中所述养生蜂蜜膏是由包括如下步骤的方法制备得到的:
(1)将干制红枣、茯苓、龙眼肉用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30~40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55~65%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50~60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
本发明的养生蜂蜜膏,通俗地讲,其是一种中药组合物。为此,根据本发明任一方面的任一实施方案,其中所述中药组合物具有如本发明任一实施例中任一项所述的配方。
根据本发明任一方面的任一实施方案,其中所中药组合物具有如本发明任一实施例中任一项所述的配方和制法。
在本发明上述制备方法的步骤中,虽然其描述的具体步骤在某些细节上或者语言描述上与下文具体实施方式部分的制备例中所描述的步骤有所区别,然而,本领域技术人员根据本发明全文的详细公开完全可以概括出以上所述方法步骤。
本发明的任一方面的任一实施方案,可以与其它实施方案进行组合,只要它们不会出现矛盾。此外,在本发明任一方面的任一实施方案中,任一技术特征可以适用于其它实施方案中的该技术特征,只要它们不会出现矛盾。下面对本发明作进一步的描述。
本发明所引述的所有文献,它们的全部内容通过引用并入本文,并且如果这些文献所表达的含义与本发明不一致时,以本发明的表述为准。此外,本发明使用的各种术语和短语具有本领域技术人员公知的一般含义,即便如此,本发明仍然希望在此对这些术语和短语作更详尽的说明和解释,提及的术语和短语如有与公知含义不一致的,以本发明所表述的含义为准。
本发明的中药组合物采用蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花制成。
蜜蜂(Apis cerana Fabr或Apis mellifera L.)是从植物的花中采取含水量约为75%的花蜜或分泌物,存入自己第二个胃中,在体内多种转化的作用下,经过15天左右反复酝酿各种维生素、矿物质和氨基酸丰富到一定的数值时,同时把花蜜中的多糖转变成人体可直接吸收的单糖葡萄糖、果糖,水分含量少于23%存贮到巢洞中,用蜂蜡密封。蜂蜜是糖的过饱和溶液,低温时会产生结晶,生成结晶的是葡萄糖,不产生结晶的部分主要是果糖。蜂蜜的成分方面,蜂蜜因蜂种、蜜源、环境之不同,其化学组成有很大差异。其主要成分是果糖和葡萄糖,两者含量合计约占70%,尚含少量蔗糖、麦芽糖、糊精、树胶以及含氮化合物、有机酸、挥发油、色素、蜡、天然香料、植物残片(特别是花粉粒)、酵母、酶类、无机盐等;蜂蜜一般只含微量维生素,其中有维生素A、维生素B1、维生素B2、维生素B6、维生素C、维生素D、维生素K、尼克酸、泛酸、叶酸、生物素、胆碱等;在含氮化合物中有蛋白质、胨、氨基酸等;尚含转化酶、过氧化氢酶、淀粉酶、氧化酶、还原酶等酶类,并含乙酰胆碱;灰分中主要含镁、钙、钾、钠、硫、磷以及微量元素铁、铜、锰、镍等;有机酸中含有柠檬酸、苹果酸、琥珀酸、甲酸、乙酸等;蜂蜜中含葡萄糖和果糖,约占65~80%;蔗糖极少,不超过8%;水分16~25%;糊精和非糖物质、矿物质、有机酸等含量在5%左右;此外,还含有少量的酵素、芳香物质和维生素等。蜜源植物品种不同,蜂蜜的成分也不一样。蜂蜜的药用功效有:蜂蜜能改进血液的成分,促进心脑和血管功用,因而常常服用对于心血管患者很有好处;蜂蜜对肝脏有维护效果,能促进肝细胞再生,对脂肪肝的形成有一定的抑制效果;食用蜂蜜能迅速弥补膂力,消除疲惫,增强对疾病的抵抗力;蜂蜜还有灭菌的效果,常常食用蜂蜜,不仅对牙齿无影响,还能在口腔内起到灭菌消毒的效果;蜂蜜能医治中度的肌肤损伤,特别是烫伤,将蜂蜜作为肌肤创伤敷料时,细菌无法成长;失眠的人在每天睡觉前口服1汤匙蜂蜜(加入1杯温开水内),能够加快进入梦乡速度;蜂蜜还能够润肠通便(只要是天然老练的真实蜂蜜都有润肠通便的效果)。蜂蜜的食用功效有:护肤美容,冬季皮肤干燥,可用少许蜂蜜调和水后涂于皮肤,可防止干裂,可用蜂蜜代替防裂膏;抗菌消炎、促进组织再生,优质蜂蜜在室温下放置数年不会腐败,表明其防腐作用极强。实验证实,蜂蜜对链球菌、葡萄球菌、白喉等革兰阳性菌有较强的抑制作用;促进消化,研究证明,蜂蜜对胃肠功能有调节作用,可使胃酸分泌正常。动物实验证实,蜂蜜有增强肠蠕动的作用,可显著缩短排便时间;提高免疫力,蜂蜜中含有的多种酶和矿物质,发生协同作用后,可以提高人体免疫力。实验研究证明,用蜂蜜饲喂小鼠,可以提高小鼠的免疫功能;保护心血管,蜂蜜有扩张冠状动脉和营养心肌的作用,改善心肌功能,对血压有调节作用;蜂蜜的功能主治:调补脾胃;缓急止痛;润肺止咳;润肠通便;润肤生肌;解毒。主脘腹虚痛;肺燥咳嗽;肠燥便秘;目赤;口疮;溃疡不敛;风疹瘙痒;水火烫伤;手足皲裂。蜂蜜味甘;性平归脾;胃;肺;大肠经。蜂蜜助减肥的原因:促进代谢,蜂蜜中所含酵素种类是所有食物种类最多的。这些酵素可以帮助人体消化吸收,促进人体的新陈代谢;改善便秘,蜂蜜具有优良的杀菌与解毒效果,可以帮助排出体内积聚的废物,如果是因为便秘症状而导致的肥胖,喝蜂蜜特别有效喔;平衡血糖降低空腹感,蜂蜜最主要的成分葡萄糖、果糖,都属于单糖,单糖在人体内不需经过消化作用,即可转化为能量被吸收利用,让血糖值上升,所以只要喝一点蜂蜜,就可以降低你的空腹感,避免吃下过多食物喔;不易积聚脂肪,蜂蜜本身不含脂肪,且相较于一般白糖,蜂蜜较轻易为人体吸收利用,只要食用适量,蜂蜜比其他甜饮不会让你囤积脂肪。
干制红枣,中国的草药书籍「本经」中记载到,红枣味甘性温、归脾胃经,有补中益气、养血安神、缓和药性的功能;而现代的药理学则发现,红枣含有蛋白质、脂肪、醣类、有机酸、维生素A、维生素C、微量钙多种氨基酸等丰富的营养成份。红枣的主要功效有:枣能提高人体免疫力,并可抑制癌细胞:药理研究发现,红枣能促进白细胞的生成,降低血清胆固醇,提高血清白蛋白,保护肝脏,红枣中还含有抑制癌细胞,甚至可使癌细胞向正常细胞转化的物质。经常食用鲜枣的人很少患胆结石,这是因为鲜枣中丰富的维生素C,使体内多余的胆固醇转变为胆汁酸,胆固醇少了,结石形成的概率也就随之减少。枣中富含钙和铁,它们对防治骨质疏松产后贫血有重要作用,中老年人更年期经常会骨质疏松,正在生长发育高峰的青少年和女性容易发生贫血,大枣对他们会有十分理想的食疗作用,其效果通常是药物不能比拟的。对病后体虚的人也有良好的滋补作用。枣所含的芦丁,是一种使血管软化,从而使血压降低的物质,对高血压病有防治功效。枣还可以抗过敏、除腥臭怪味、宁心安神、益智健脑、增强食欲。
茯苓,为多孔菌科真菌茯苓Poria cocos(Schw.)Wolf的干燥菌核。多于7~9月采挖,挖出后除去泥沙,堆置“发汗”后,摊开晾至表面干燥,再“发汗”,反复数次至现皱纹、内部水分大部散失后,阴干,称为“茯苓个”;或将鲜茯苓按不同部位切制,阴干,分别称为“茯苓块”和“茯苓片”。茯苓的性味:味甘、淡,性平。归经:归心、肺、脾、肾经。功效:利水渗湿,健脾,宁心。主治:用于水肿尿少,痰饮眩悸,脾虚食少,便溏泄泻,心神不安,惊悸失眠。产地:分布河北、河南、山东、安徽、浙江、福建、广东、广西、湖南、湖北、四川、贵州、云南、山西等地。主产于安徽、云南、湖北。《本草纲目》载:茯苓气味淡而渗,其性上行,生津液,开腠理,滋水源而下降,利小便,故张洁古谓其属阳,浮而升,言其性也;东垣谓其为阳中之阴,降而下,言其功也。《本草衍义》载:茯苓、茯神,行水之功多,益心脾不可阙也。《本草正》载:能利窍去湿,利窍则开心益智,导浊生津;去湿则逐水燥脾,补中健胃;袪惊痫,厚肠脏,治痰之本,助药之降。以其味有微甘,故曰补阳;但补少利多。
龙眼肉(Dried Longan Pulp),是指鲜龙眼烘成干果后即成为中药里的桂圆。生药龙眼肉为由顶端纵向裂开有不规则块片,气香,味浓甜而特殊。表面黄棕色,半透明;靠近果皮的一面皱缩不平,粗糙,靠近种皮的一面,光亮而有纵皱纹。龙眼肉,长约1.5厘米,宽1.3~3.5厘米,厚不及1毫米。质柔软而微有粘性,常粘结呈块状。而桂圆因其种圆黑光泽,种脐突起呈白色,看似传说中“龙”的眼睛,所以得名。新鲜的龙眼肉质极嫩,汁多甜蜜,美味可口,实为其他果品所不及。龙眼肉的营养价值:每100克龙眼中,水分占83%,含蛋白质1.3克、脂肪0.1克、碳水化合物15克和纤维0.4克。龙眼含有极其丰富的维生素C和钾,此外还含有大量的镁和铜,有补气益血之功效,对于治疗虚劳羸弱、失眠、健忘效果显著。果肉(干)含水分0.85%,可溶性物质79.77%,不溶性物质19.4%,灰分3.36%。可溶性物质中,有葡萄糖24%、蔗糖0.22%、酸类(酒石酸)1.26%、含氮物(其中含腺嘌呤和胆碱)6.3%等。尚含蛋白质5.6%、脂肪0.5%。龙眼肉的膳食价值:补益心脾,养血安神。用于气血不足、心悸怔忡、健忘失眠、血虚萎黄。龙眼肉为无患子科植物龙眼的假种皮,又名益智、蜜脾、桂圆。主产于广东、福建、台湾、广西、云南、贵州、四川等地。7月至10月果熟时采摘,烘干或晒干,取肉去核晒至干爽不粘。龙眼肉是《中华人民共和国药典》的法定药物,理想的补品。中医认为,龙眼味甘、性温。入心、脾经。具有补益心脾、养血宁神、健脾止泻、利尿消肿等功效。适用于病后体虚、血虚萎黄、气血不足、神经衰弱、心悸怔忡、健忘失眠等病症。早在汉朝时期,龙眼就已作为药用。李时珍说:“龙眼大补”,“食品以荔枝为贵,而资益则龙眼为良。”《日用本草》:“益智宁心。”《得配本草》认为:龙眼“益脾胃,葆心血,润五脏,治怔忡。”《泉州本草》认为:龙眼“壮阳益气,补脾胃。”《药品化义》)曰:“桂圆,当归,滋肝补血。”至今,龙眼仍然是一味补血安神的重要药物。据现代研究,龙眼鲜食,味甜美爽口,且营养价值甚高,富含高碳水化合物、蛋白质、多种氨基酸和维生素B、C、钙、磷、铁、酒石酸、腺膘呤等,其中尤以含维生素P量多,对中老年人而言,有保护血管、防止血管硬化和脆性的作用。国外在研究龙眼时发现其含有一种活性成分有抗衰老的作用。这与我国最早的药学专著《神农本草经》中所言龙眼有轻身不老之说相吻合。故此有人认为龙眼是具有较好开发潜质的抗衰老食品。日本大阪中医研究所曾对800多种天然食、药物进行抗癌试验,发现龙眼肉的水浸液对子宫颈癌细胞有九成以上的抑制率。龙眼所含糖分量很高,为易消化吸收的单糖,可以被人体直接吸收,故体弱贫血,年老体衰,久病体虚,经常吃些龙眼是很有补益作用;妇女产后,龙眼也是重要的调补食品。因含铁及维生素B2很丰富,可以减轻子宫收缩及宫体下垂感。对于妇女产后、体虚乏力、贫血等,则可用龙眼肉加入当归、枸杞、红枣(去核)数颗炖鸡。或每日食用龙眼肉煮鸡蛋,可活血调经,促进体力恢复。龙眼除可以直接嚼服、水煎服用外,也可制成果羹、浸酒,还可与白沙糖共同熬成膏剂服用。但是,脾胃有痰火及湿滞停饮、消化不良、恶心呕吐者忌服。孕妇,尤其妊娠早期,则不宜服用龙眼肉,以防胎动及早产等。此外,因其葡萄糖含量较高,故糖尿病患者不宜多服。新鲜的龙眼,营养丰富,味道鲜美,进食时要注意切不可吃未熟透的龙眼,因容易引起哮喘病。龙眼肉作为食疗品每次食用量以干品6克为宜。龙眼肉的药用价值:1.益气补血,增强记忆:桂圆(龙眼干)含丰富的葡萄糖、蔗糖及蛋白质等,含铁量也较高,可在提高热能、补充营养的同时,又能促进血红蛋白再生以补血。实验研究发现,桂圆肉(龙眼干)除对全身有补益作用外,对脑细胞特别有益,能增强记忆,消除疲劳。2.安神定志:桂圆(龙眼干)含有大量的铁、钾等元素,能促进血红蛋白的再生以治疗因贫血造成的心悸、心慌、失眠、健忘。桂圆(龙眼干)中含尼克酸高达2.5毫克(每100克),可用于治疗尼克酸缺乏造成的皮炎、腹泻、痴呆,甚至精神失常等。3.养血安胎:桂圆(龙眼干)含铁及维生素比较多,可减轻宫缩及下垂感,对于加速代谢的孕妇及胎儿的发育有利,具有安胎作用。4.抗菌,抑制癌细胞:动物实验表明,桂圆(龙眼干)对JTC-26肿瘤抑制率达90%以上,对癌细胞有一定的抑制作用。临床给癌症患者口服桂圆粗制浸膏,症状改善90%,延长寿命效果约80%。此外,桂圆(龙眼干)水浸剂(1∶2)在试管内对奥杜盎小芽孢癣菌有抑制作用。5.降脂护心,延缓衰老:桂圆肉(龙眼干)可降血脂,增加冠状动脉血流量。对与衰老过程有密切关系的黄素蛋白——脑B型单胺氧化酶(MAO-B)有较强的抑制作用。
金银花,正名为忍冬(学名:Lonicera japonica Thunb.)。“金银花”一名出自《本草纲目》,由于忍冬花初开为白色,后转为黄色,因此得名金银花。药材金银花为忍冬科忍冬属植物忍冬及同属植物干燥花蕾或带初开的花。《神农本草经》载:“金银花性寒味甘,具有清热解毒、凉血化淤之功效,主治外感风热、瘟病初起、疮疡疔毒、红肿热痛、便脓血”等。《本草纲目》中详细论述了金银花具有“久服轻身、延年益寿”的功效。二十世纪八十年代,国家卫生部对金银花先后进行了化学分析,结果表明:金银花含有多种人体必须的微量元素和化学成分,同时含有多种对人体有利的活性酶物质,具有抗衰老,防癌变,轻身健体的良好功效。金银花最早栽培记载见于宋代《苏沈内翰良方》,其中称:“可移根庭栏间,以备急。”许多地方县志也有记载,如清光绪二十二年《费县志》称:“花有黄白故名金银花,从前间有之,不过采以代茶,至嘉庆初,商旅贩往他处,……不数年山角水湄栽植几遍。”由此可知,金银花有着悠久的栽培历史。1984年国家中医药管理局将其确定为35种名贵中药材之一,后来又被确定为药食兼用品种。金银花药用历史悠久,早在3000年前,我们祖先就开始用它防治疾病,在《名医别录》中被列为上品。金银花自古以来就以它的药用价值广泛而著名。其功效主要是清热解毒,主治温病发热、热毒血痢、痈疽疔毒等。现代研究证明,金银花含有绿原酸、木犀草素苷等药理活性成分,对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力,另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇等,其临床用途非常广泛,可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。金银花性寒,味甘,入肺、心、胃经,具有清热解毒、抗炎、补虚疗风的功效,主治胀满下疾、温病发热,热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。金银花藤煲水后对小孩湿疹等皮肤瘙痒有一定治疗作用,对畜禽的多种至病的病菌、病毒有抑制作用,在动物饲养过程中若能添加一定剂量的金银花藤叶(忍冬藤)粉或煲水,对预防和治疗动物的温病发热、风热感冒、咽喉炎症、肺炎、痢疾、肿溃疡、丹毒、蜂窝组织炎等症均有相当好的作用。用连翘,板蓝根煎金银花汤可以治疗腮腺炎;金银花茶可以祛暑明目;连翘金银花凉汤可治疗外感发热咳嗽。同时将金银花、菊花、桔梗和甘草加水煮沸10分钟,侯凉,当饮料饮用,可治疗咽喉炎和扁桃体炎。已生产的金银花制剂有“银翘解毒片”、“银黄片”、“银黄注射液”等。“金银花露”是金银花用蒸馏法提取的芳香性挥发油及水溶性溜出物,为清火解毒的良品,可治小儿胎毒、疮疖、发热口渴等症;暑季用以代茶,能治温热痧痘、血痢等。茎藤称“忍冬藤”,也供药用。金银花的有效成份为绿原酸和异绿原酸。这是植物代谢过程中产生的次生物质,其含量的高低不仅取决于植物的种类,而且可能在很大程度上受气候、土壤等生态、地理条件以及物候期的影响。金银花茶有独特的减肥功能,还能抑制与杀灭咽喉部的病原菌,对老人和儿童有抗感染功效。经常服用金银花浸泡或煎剂有利于风火目赤、咽喉肿痛、肥胖症、肝热症和肝热型高血压的治疗与康复。金银花在临床上的应用如下:温病初期:常与;连翘、薄荷、淡豆鼓等同用,具有清热解毒、疏风解表作用,可用以温病初期,发热微恶寒风寒,口微渴,如银翘散。痈疽疔毒:常与蒲公英、紫地丁、野菊花等同用,能增强清热解毒作用,可用以痈疽疔毒,红肿疼痛,如五味消毒饮。温病中期:常与黄芩、栀子、石膏、竹茹、芦根等同用,具有清热解毒、透邪外出、和胃止呕作用,可用以邪热壅阻,胃气不和,发热烦躁,胸膈痞闷,口渴干呕,舌红苔燥,脉象滑数。赤痢:常与黄连、赤芍、木香、马齿苋等同用,具有清热理肠、化滞和血作用,可用以湿热中阻、损伤肠络脂膜,下痢脓血,血多于脓,腹痛,里急后重。疫痢:常与生地黄、赤芍、丹皮、黄连、黄柏、白头翁等同用,具有清热解毒、凉血止痢作用,可用以疫毒侵袭肠胃,与气血搏结,痢下鲜紫脓血,壮热口渴,烦躁不安,甚至神昏谵语。金银花的药毒理学方面,金银花水浸液灌胃,对家兔、犬等无明显毒性反应,对呼吸、血压、尿量均无影响。小鼠皮下注射本品浸膏的LD50为53g/kg。绿原酸具有致敏原作用,可引起变态反应,但口服无此反应,因绿原酸可为小肠分泌物转化为无致敏活性的物质。溶血试验结果表明:蒸晒品0.1~0.5mL均在3小时内无溶血现象;生晒品0.1~0.5mL在加药后立即出现溶血现象;贵州山银花0.1~0.5mL均在3小时内无溶血现象;河南蜜银花pH6.0时0.1~0.3mL无溶血现象;山东济银花:0.1~0.5mL均在3小时无溶血现象。5种材料的LD50顺序为:蜜银花<济银花<蒸晒品<贵州商品,灰毡毛忍冬蒸晒品无溶血性,而生晒的有溶血性,故作注射液原料,必须采用蒸晒品。具体地说,1、抗病原微生物作用:体外实验表明,花和藤对多种致病菌如金黄色葡萄球菌、溶血性链球菌、大肠杆菌、痢疾杆菌、霍乱弧菌、伤寒杆菌、副伤寒杆菌等均有一定抑制作用,对肺炎球菌、脑膜炎双球菌、绿脓杆菌、结核杆菌亦有效。水浸剂比煎剂作用强,叶煎剂比花煎剂作用强。若和连翘合用,抗菌范围还可互补;与青霉素合用,能加强青霉素对耐药金黄色葡萄球菌的抗菌作用,这可能是在抑制细菌体内蛋白质合成上有协同的作用。2、抗炎和解热作用:腹腔注射金银花提取液0.25g/kg,能抑制大鼠角叉菜胶性脚肿。另有报道金银花注射液30~40g/kg能减轻蛋清性脚肿程度。腹腔注射金银花提取液8g/kg,2次/天,连续6天,对大鼠巴豆油性肉芽囊,也有明显抗渗出和抗增生的作用。早期报道金银花具有明显的解热作用,但用霍乱菌苗、马铃薯杆菌、枯草浸液等给家兔耳静脉注射,致热,未证实金银花煎剂5g/kg灌胃有退热作用,认为这可能和使用的金银花制剂、剂量或家兔的耐受性不同有关。3、加强免疫机能作用:金银花煎剂稀释至1:1280的浓度,仍能促进白细胞的吞噬功能。小鼠腹腔注射金银花注射液,也有明显促进炎性细胞吞噬功能的作用。4、中枢兴奋作用:经电休克、转笼等多种实验方法证明口服绿原酸后,可引起大鼠、小鼠等动物中枢神经系统兴奋,其作用强度为咖啡因的1/6,二者合用无相加及增强作用。5、降血脂作用:大鼠灌胃金银花2.5g/kg能减少肠内胆固醇吸收,降低血浆中胆固醇含量。体外实验也发现金银花可和胆固醇相结合,但四妙勇安汤(金银花、玄参、当归、甘草)治疗家兔实验性动脉粥样硬化。未观察到有降血脂和主动脉壁胆固醇含量的作用。6、抗内毒素:用鲎试验法测定内毒素含量,300%金银花(忍冬)注射液以1:2~1:64稀释,体外试验无论用凹片法或试管法,均明显降低试液中的内毒素含量,其中1:2~1:8的稀释管与阴性对照管一样呈液态,阳性对照呈凝胶状。金银花(忍冬)蒸馏液6g/kg静脉注射,对绿脓杆菌内毒互2.8mg/kg静脉注射引起的兔体温下降及白细胞数下降有对抗作用,金银花(忍冬)蒸馏液7.5g/kg或注射液2.5g/kg腹腔注射,对绿脓杆菌内毒素65mg/kg腹腔注射的小鼠有保护作用,减少小鼠死亡率。7、其它作用:曾有体外筛选实验报告金银花的水及酒浸液对肉瘤180及艾氏腹水癌有明显的细胞毒作用。金银花提取物口服对大鼠实验性胃溃疡有轻度预防效果。口服大剂量绿原酸能增加胃肠蠕动,促进胃液及胆汁分泌。绿原酸及其分解产物对大鼠离体子宫有兴奋作用。此外,绿原酸还能轻微增强肾上腺素及其去甲肾上腺素对猫和大鼠的升压作用,但对猫的瞬膜反应无影响。
阿胶为马科动物驴的皮去毛后熬制而成的胶块。动物形态详驴肉条。功能主治为:滋阴补血,安胎。治血虚,虚劳咳嗽,吐血,衄血、便血,妇女月经不调,崩中,胎漏。①《本经》:主心腹内崩,劳极洒洒如疟状,腰腹痛,四肢酸疼,女子下血。安胎。久服益气。②《别录》:丈夫小腹痛,虚劳羸瘦,阴气不足,脚酸不能久立,养肝气。③《药性论》:主坚筋骨,益气止痢。④《千金·食治》:治大风。⑤孟诜:治一切风毒骨节痛,呻吟不止者,消和洒服。⑥《日华子本草》:治一切风,并鼻洪、吐血、肠风、血痢及崩中带下。⑦《纲目》:疗吐血、衄血、血淋、尿血,肠风,下痢。女人血痛、血枯、经水不调,无子,崩中,带下,胎前产后诸疾。男女一切风病,骨节疼痛,水气浮肿,虚劳咳嗽喘急,肺痿唾脓血,及痈疽肿毒。和血滋阴,除风润燥,化痰清肺,利小便,调大肠。⑧《纲目拾遗》:治内伤腰痛,强力伸筋,添精固肾。阿胶性甘、味平。阿胶的功能主治有:滋阴补血,安胎;治血虚,虚劳咳嗽,吐血,衄血、便血,妇女月经不调,崩中,胎漏。阿胶的药理作用主要有:1.对血细胞影响大量抽血造成犬失血性贫血后,用阿胶溶液灌胃(30克/天,共10天),其红细胞和血红蛋白增加的速度比对照组快。2.对钙代谢的影响阿胶能改善动物体内钙平衡。用阿胶灌胃,同时在食物中加碳酸钙,能增加钙的吸收和在体内的潴留,使血钙略有增高;这种钙质载运作用可能与阿胶中所含甘氨酸有关。3.防治进行性肌营养障碍症的作用用特别饲料喂养豚鼠,使全部造成进行性肌营养障碍症,加用阿胶者,仅20%发生,多数皆健全无症状。已发生此症后,再用阿胶,亦可使病症逐渐减轻。作者认为维生素E可防治此症,阿胶有效原因,可能与其能防止饲料中维生素E的氧化破坏有关。该特殊饲料里有中等量的维生素E,但因亦含动物性脂肪,易使维生素E氧化失效而造成此症。4.其他作用猫试验证明,在它创伤性休克危急期,用生理盐水亦难挽救的情况下,注射阿胶精制溶液,可使血压上升而转危为安。用市售阿胶于4例胆囊造影者(15~20克,加水冲服),仅1人有明显胆囊收缩,余3例无改变。阿胶多由胶原及其部分水解产物所成,含氮16.43~16.54%,基本上是蛋白质。水解产生多种氨基酸,其中有赖氨酸10%、精氨酸7%、组氨酸2%等。从产生的氨基酸看,阿胶与明胶相似,但前者之赖氨酸较多,且含胱氨酸,而缺乏色氨酸。含灰分0.75~1.09%,钙0.079~0.118%。
辣木叶(horseradish tree leaves)指原产于印度的多年生热带落叶乔木辣木树(又称为鼓槌树)的树叶,可食用。辣木的种子和叶子中含有丰富的营养成分。有降血糖、降脂、降压、抗肿瘤等的功效。辣木有“奇迹树”、“母亲最好的朋友”和“医药百宝箱”之称。在非洲,它被称为穷人的牛奶;在印度,辣木已经有上千年的食用历史,已成为日常生活不可或缺的食物之一。一般公认为辣木叶具有降血糖、降脂、降压、抗肿瘤等功效。辣木叶是一种高钙植物产品,含钙量是牛奶的4倍以上,除此以外,还含有很高的钾、铁、锌等微量元素,含有跟大豆差不多的蛋白质以及氨基酸等,是一种含全营养素的功能食品,一个人每天只要吃上5克左右即可供给人体一天的营养需要,因此它可以补钙、补铁、补钾、补锌四补,可以为减肥消费者提供足够的营养需要而不至于因节食而损伤肌体。辣木叶粉精选幼嫩辣木叶.经超微粉碎而成.具有全面补充营养,提高免疫力,排毒养颜,通肠利便,减肥等功效。辣木叶粉营养丰富而全面,维生素E分别是螺旋藻和黄豆粉的70倍和40倍。在我国台湾称作“21世纪人体保镖”。晴林孙(L.S.Ching)辣木等人于2001年发表的文献中记载,100克印度传统辣木的新鲜叶片中的维他命E含量约为9毫克,干燥叶片中的含量约为16.2毫克。根据计算,只要三汤匙(约25克)的辣木叶干粉就含有幼儿每日所需270%的维生素A,42%的蛋白质,125%的钙,70%的铁及22%的维生素C。对怀孕和哺乳中的女性而言,辣木叶片和豆荚亦可帮助本人及胎儿或婴儿维持健康,供给大量的铁质、蛋白质、铜、硫和维他命B。不过,由于辣木本身含有植物碱,高血压、糖尿病患者及孕妇等最好经医师指示后酌量食用。辣木叶片、果荚富含多种矿物质、维生素、20种氨基酸、46种抗氧素和36种自然防炎体和矿物质。每100克的辣木中含有的维生素C是柑橘的7倍,铁是菠菜的3倍,维生素A是胡萝卜的4倍,钙质是牛奶的4倍,钾是香蕉的3倍,蛋白质是酸奶的2倍。作为蔬菜和食品有增进营养,食疗保健的功能;也广泛应用于医药、保健等方面,被誉为“生命之树”,“植物中的钻石”。辣木叶具有降血糖、降脂、降压、抗肿瘤、抗氧化、通便、利尿、驱虫、改善睡眠等功效,长期食用可增强人体免疫功能,延缓衰老、预防疾病。印度草医学认为辣木可预防300种疾病。特别是近几年辣木受到欧美等发达国家很多研究机构和消费者的关注和热捧。经常食用辣木叶可增强免疫力、排毒、塑身、抗老化、抗癌、并对多种慢性及重大疾病都有极大的改善功效。辣木叶是纯天然绿色食品,含有人体所需的全部营养物质,它可取代复合维生素、钙片、鱼肝油等。特别对高血压、高血脂、糖尿病、痛风等有很好的效果。辣木叶可协助改善、预防疾病,改善睡眠、增强记忆力、延缓衰老,还可用来治疗肝脏、脾脏、经络等特殊部位的疾病。它还具有治疗口臭和醒酒等作用。辣木叶的适用人群主要有:需补充维生素A、E、B和钙、铁等矿物质的人群;低血压、高血压、糖尿病、肥胖症、癌症和便秘等患者;长期使用电脑者。
玫瑰花为蔷薇科植物玫瑰和重瓣玫瑰的花。玫瑰和重瓣玫瑰属落叶灌木,原产中国北部,现全国各地均有栽培。以山东、江苏、浙江及广东最多。5至6月盛花期前,采摘已充分膨大但未开放的花蕾,文火烘干或阴干;或采后装入纸袋,贮于石灰缸内,封盖,每年梅雨期更换新石灰。玫瑰花花蕾呈卵形,半球形或不规则团块,直径1至2.5厘米,花托壶形或半球形,与花萼基部相连。萼片5枚,披针形,黄棕色或棕绿色,其内表面被细柔毛,花瓣5或重瓣,广卵圆形,多皱缩,紫红色,少数黄棕色。雄蕊多数,黄褐色体轻,质脆。香气浓郁,味微苦、涩。以花蕾大,完整瓣厚,色紫鲜,不露蕊,香气浓者为佳。食疗作用方面,玫瑰花味甘微苦、性微温,归肝、脾、胃经;芳香行散;具有舒肝解郁,和血调经的功效;主治胸膈满闷,胃脘、胁肋、乳房胀痛,月经不调,赤白带下,泄泻痢疾,跌打损伤,风痹,痈肿。中药用途方面,玫瑰花味甘、微苦,气香性温。玫瑰花含有少量挥发油和黄色结晶性煎、揉质、没食子酸、色素等。玫瑰油中主要成分为醇类化合物。玫瑰花具有利气、行血,治风痹,散疲止痛。玫瑰花及全株都有收敛性,可用于妇女月经过多,赤白带下以及肠炎、下痢、肠红半截出血等。理气解郁、和血散瘀。主治肝胃气痛,新久风痹,吐血咯血,月经不调,赤白带下,痢疾、乳痈,肿毒。《食物本草》谓其“主利肺脾、益肝胆,食之芳香甘美,令人神爽。”长期服用,美容效果甚佳,能有效地清除自由基,消除色素沉着,令人唤发青春活力。玫瑰花味甘,性温,气味芳香,药性平和,具有理气和血、排毒养颜、和血散淤、开窍化淤、疏肝醒脾、促进胆汁分泌、帮助消化、调节机理的功效。主要适用于肝胃不和所致的胁痛脘闷、胃脘胀痛及月经不调或经前乳房胀痛者。此外,玫瑰花还含有多种营养成分,对某些皮肤病有很好的疗效,长期使用能彻底去除痤疮和粉刺,使面部的皮肤光滑柔嫩,对治疗面部黄褐斑有一定作用。
本发明的养生蜂蜜膏采用蜂蜜、干制红枣、茯苓、龙眼肉、金银花、阿胶、辣木叶、玫瑰花制成。呈现这些药材的组合生物学功效,特别是具有显著的补中益气、养血安神和调节人体机能的功效。例如,针对气血不足、心神不宁受试者22人,每人每天给予本发明实施例1所得养生蜂蜜膏20g,分早晚两次服用,1个月后,全部受试者的气血不足、心神不宁的状态均完全消失。这表明,本发明的养生蜂蜜膏具有优异的调节人体机能的效果。
另外,基于本发明养生蜂蜜膏中的各种药材的生理学性能,完全可以预期本发明养生蜂蜜膏能够呈现这些药材各自或组合产生的生物学效应,例如本发明养生蜂蜜膏能够被赋予蜜蜂典型的用于改善心血管功能、促进肝细胞再生、抗菌消炎、促进组织再生、增强肠蠕动、提高免疫力、调补脾胃、缓急止痛、润肺止咳、润肠通便、润肤生肌、解毒、脘腹虚痛、肺燥咳嗽、肠燥便秘、目赤、口疮、溃疡不敛、风疹瘙痒、水火烫伤、手足皲裂的功效;干制红枣典型的用于提高人体免疫力、抑制癌细胞、促进白细胞生成、降低血清胆固醇、提高血清白蛋白、保护肝脏、防治骨质疏松和产后贫血、抗过敏、除腥臭怪味、宁心安神、益智健脑、增强食欲的功效;茯苓典型的用于利水渗湿、健脾、宁心、水肿尿少,痰饮眩悸、脾虚食少、便溏泄泻、心神不安、惊悸失眠、龙眼肉、补益心脾、养血安神、健脾止泻、利尿消肿、用于气血不足、心悸怔忡、健忘失眠、血虚萎黄、保护血管、防止血管硬化和脆性、增强记忆、养血安胎、抗菌、抑制癌细胞、降脂护心、延缓衰老的功效;金银花典型的用于清热解毒、凉血化淤效果,以及增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血(凝血)、抑制肠道吸收胆固醇的功效;阿胶典型的用于滋阴补血、安胎、治血虚、虚劳咳嗽、吐血、衄血、便血、妇女月经不调、崩中、胎漏的功效;辣木叶典型的用于降血糖、降脂、降压、抗肿瘤、提高免疫力、排毒养颜、通肠利便、减肥的功效;玫瑰花典型的用于胸膈满闷、胃脘、胁肋、乳房胀痛、月经不调、赤白带下、泄泻痢疾、跌打损伤、风痹、痈肿的功效。特别是例如完全可以预期本发明养生蜂蜜膏具有优异的综合生物学功能特别是治疗、预防和保健功能,特别是具有清除自由基、抗氧化、抗血栓、抗肿瘤、消炎等多方面的药效学作用。因此,本发明第三方面的用途还包括上述这些治疗/预防效果所涉及的用途。
具体实施方式
通过下面的实施例可以对本发明进行进一步的描述,然而,本发明的范围并不限于下述实施例。本领域的专业人员能够理解,在不背离本发明的精神和范围的前提下,可以对本发明进行各种变化和修饰。本发明对试验中所使用到的材料以及试验方法进行一般性和/或具体的描述。虽然为实现本发明目的所使用的许多材料和操作方法是本领域公知的,但是本发明仍然在此作尽可能详细描述。
实施例1:制备养生蜂蜜膏
配方:蜂蜜100克、干制红枣100克、茯苓30克、龙眼肉30克、金银花30克、阿胶10克、辣木叶150克、玫瑰花150克、果葡糖浆10克。
制法:
(1)将干制红枣、茯苓、龙眼肉用5倍量的水煎煮提取2小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加5倍量的水煎煮提取1.5小时,滤取煎液保温保存;滤渣加3倍量的水煎煮提取0.75小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达35%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达50%,搅拌均匀,静置2.5小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于55℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
实施例2:制备养生蜂蜜膏
配方:蜂蜜100克、干制红枣200克、茯苓20克、龙眼肉100克、金银花20克、阿胶30克、辣木叶50克、玫瑰花500克、果葡糖浆5克。
制法:
(1)将干制红枣、茯苓、龙眼肉用4倍量的水煎煮提取1小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加6倍量的水煎煮提取1小时,滤取煎液保温保存;滤渣加2倍量的水煎煮提取0.5小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55%,搅拌均匀,静置3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
实施例3:制备养生蜂蜜膏
配方:蜂蜜100克、干制红枣50克、茯苓100克、龙眼肉20克、金银花100克、阿胶5克、辣木叶500克、玫瑰花50克、果葡糖浆25克。
制法:
(1)将干制红枣、茯苓、龙眼肉用6倍量的水煎煮提取3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4倍量的水煎煮提取2小时,滤取煎液保温保存;滤渣加4倍量的水煎煮提取1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达65%,搅拌均匀,静置2小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
实施例4:制备养生蜂蜜膏
配方:蜂蜜100克、干制红枣50克、茯苓50克、龙眼肉20克、金银花50克、阿胶5克、辣木叶200克、玫瑰花100克、果葡糖浆20克。
制法:
(1)将干制红枣、茯苓、龙眼肉用4.5倍量的水煎煮提取1.5小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加5.5倍量的水煎煮提取1.5小时,滤取煎液保温保存;滤渣加3.5倍量的水煎煮提取0.5小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达35%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55%,搅拌均匀,静置2小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
实施例5:制备养生蜂蜜膏
配方:蜂蜜100克、干制红枣150克、茯苓20克、龙眼肉50克、金银花20克、阿胶20克、辣木叶100克、玫瑰花250克、果葡糖浆5克。
制法:
(1)将干制红枣、茯苓、龙眼肉用5.5倍量的水煎煮提取2.5小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4.5倍量的水煎煮提取1.5小时,滤取煎液保温保存;滤渣加2.5倍量的水煎煮提取1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80℃保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达38%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达65%,搅拌均匀,静置3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于60℃减压浓缩至相对密度1.25~1.30(25℃),加入蜂蜜,搅匀,即得养生蜂蜜膏。
实施例6:制备养生蜂蜜膏
配方和制法分别参照实施例1~5进行,不同的仅是:果葡糖浆在步骤(4)烊化搅匀后添加,得到5批养生蜂蜜膏样品。作为一种常规的药用辅料特别是通常作为调味剂,果葡糖浆在此步骤阶段添加是本领域通用的生产实践。
试验例1:醇沉去除沉淀物量的考察
在实施例1~6的步骤(3)中,在经过两次醇沉、两次过滤后,将两次滤出的滤饼合并、干燥,称重,比较实施例6进行的五个制备试验与相应的实施例1~5制备试验中滤饼干重(即,例如,将实施例6之参照实施例1配方和制法进行的试验,与实施例1进行的试验,此相应的二者进行比较),以下式计算实施例1~5中的沉淀去除率(%):
去除率(%)=[实施例1~5相应试验滤饼干重÷实施例6某试验滤饼干重]×100%
上述去除率(%)越大,则表示实施例1~5某试验中醇沉效果更好(相对于其实施例6相应试验而言)。已经发现实施例1的沉淀去除率达143%,实施例2~5各自的沉淀去除率亦136~145%范围。这表明,相对于实施例6而言,实施例1~5在步骤(3)中添加果葡糖浆能够更有效的实现醇沉除沉淀物的效果。
试验例2:测定绿原酸
绿原酸的含量测定方法:
照高效液相色谱法(中国药典2015年版四部通则0512)的规范测定;
色谱条件与系统适用性试验:以十八烷基硅烷键合硅胶为填充剂;以乙腈-0.4%磷酸溶液(13:87)为流动相;检测波长为327nm。理论板数按绿原酸峰计算应不低于1000;
对照品溶液的制备:取绿原酸对照品适量,精密称定,置棕色量瓶中,加50%甲醇制成每1ml含40μg的溶液,即得(10℃以下保存)。
供试品溶液的制备:取供试品适量(约相当于金银花药材0.5g),精密称定,置具塞锥形瓶中,精密加入50%甲醇50ml,称定重量,超声处理(功率250W,频率35kHz)30分钟,放冷,再称定重量,用50%甲醇补足减失的重量,摇匀,滤过,精密量取续滤液5ml,置25ml棕色量瓶中,加50%甲醇至刻度,摇匀,即得。
测定法:分别精密吸取对照品溶液与供试品溶液各5~10μl注入液相色谱仪,测定,即得供试品中绿原酸(C16H18O9)的含量。
对于实施例1~6的十次试验,测定投料金银花中绿原酸含量,根据金银花投料量计算绿原酸的理论投料量,然后测定并计算最终所得养生蜂蜜膏成品中的绿原酸的收获量,以下式计算绿原酸的收获率(%):
收获率(%)=[养生蜂蜜膏成品中的绿原酸收获量÷金银花中的绿原酸理论投料量]×100%
结果:实施例1~5的绿原酸收获率在86~91%范围,而实施例6的绿原酸收获率在61~65%范围,与在醇沉过程中添加果葡糖浆的情形相比,在醇沉完毕后再加果葡糖浆时绿原酸收获率低20个百分点以上,例如实施例1的绿原酸收获率为89%,而实施例6之参照实施例1试验的绿原酸收获率为63%,相对而言收获率低26个百分点。
以上所揭露的仅为本发明的较佳实施例而已,当然不能以此来限定本发明的权利范围,因此依本发明申请专利范围所作的等同变化,仍属本发明所涵盖的范围。
Claims (4)
1.一种养生蜂蜜膏,其是由如下的组分制备得到的:蜂蜜100克、干制红枣50~200克、茯苓20~100克、龙眼肉20~100克、金银花20~100克、阿胶5~30克、辣木叶50~500克、玫瑰花50~500克、果葡糖浆5~25克;该养生蜂蜜膏是由包括如下步骤的方法制备得到的:
(1)将干制红枣、茯苓、龙眼肉用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80°C保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30~40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55~65%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50~60°C减压浓缩至25°C下测定的相对密度为1.25~1.30,加入蜂蜜,搅匀,即得养生蜂蜜膏。
2.根据权利要求1的养生蜂蜜膏,以每100克蜂蜜计,果葡糖浆的量为5~20克。
3.根据权利要求1的养生蜂蜜膏,以每100克蜂蜜计,果葡糖浆的量为10克。
4.制备权利要求1-3任一项所述养生蜂蜜膏的方法,包括如下步骤:
(1)将干制红枣、茯苓、龙眼肉用4~6倍量的水煎煮提取1~3小时,滤取煎液保温保存,滤渣备用;
(2)将滤渣、金银花、辣木叶和玫瑰花加4~6倍量的水煎煮提取1~2小时,滤取煎液保温保存;滤渣加2~4倍量的水煎煮提取0.5~1小时,滤取煎液保温保存;
(3)将合并的三次煎液于70~80°C保温保存,加入果葡糖浆,搅拌均匀,在保温状态下加入乙醇至含醇量达30~40%,搅拌均匀,自然降温至室温后静置2小时,过滤取清液,弃沉淀;清液继续加乙醇至含醇量达55~65%,搅拌均匀,静置2~3小时,过滤取清液;
(4)使阿胶加至步骤(3)所得清液中,烊化搅匀,于50~60°C减压浓缩至25°C下测定的相对密度为1.25~1.30,加入蜂蜜,搅匀,即得养生蜂蜜膏。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810521071.4A CN108813500B (zh) | 2018-05-28 | 2018-05-28 | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810521071.4A CN108813500B (zh) | 2018-05-28 | 2018-05-28 | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108813500A CN108813500A (zh) | 2018-11-16 |
CN108813500B true CN108813500B (zh) | 2021-09-21 |
Family
ID=64145866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810521071.4A Active CN108813500B (zh) | 2018-05-28 | 2018-05-28 | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108813500B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115005352B (zh) * | 2022-06-17 | 2023-04-11 | 日照壳美乐海洋生物科技有限公司 | 一种壳寡糖复合阿胶蛋白肽的组合物及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101779755A (zh) * | 2009-12-18 | 2010-07-21 | 芜湖盛开营养食品有限公司 | 一种蜂蜜膏 |
CN102511868A (zh) * | 2011-12-29 | 2012-06-27 | 山西汉波食品股份有限公司 | 一种添加维生素的红枣阿胶浓浆 |
CN106617049A (zh) * | 2016-09-29 | 2017-05-10 | 广州市汇吉科技企业孵化器有限公司 | 一种含辣木叶提取物的蜂胶类保健品及其制备方法 |
JP2017165686A (ja) * | 2016-03-16 | 2017-09-21 | 株式会社東洋新薬 | 肝機能改善剤 |
CN107927677A (zh) * | 2017-12-19 | 2018-04-20 | 安徽蜂献蜂业有限公司 | 一种保健水果蜂蜜膏及其加工方法 |
CN108030081A (zh) * | 2017-12-19 | 2018-05-15 | 安徽蜂献蜂业有限公司 | 一种木瓜养颜蜂蜜膏及其加工方法 |
-
2018
- 2018-05-28 CN CN201810521071.4A patent/CN108813500B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101779755A (zh) * | 2009-12-18 | 2010-07-21 | 芜湖盛开营养食品有限公司 | 一种蜂蜜膏 |
CN102511868A (zh) * | 2011-12-29 | 2012-06-27 | 山西汉波食品股份有限公司 | 一种添加维生素的红枣阿胶浓浆 |
JP2017165686A (ja) * | 2016-03-16 | 2017-09-21 | 株式会社東洋新薬 | 肝機能改善剤 |
CN106617049A (zh) * | 2016-09-29 | 2017-05-10 | 广州市汇吉科技企业孵化器有限公司 | 一种含辣木叶提取物的蜂胶类保健品及其制备方法 |
CN107927677A (zh) * | 2017-12-19 | 2018-04-20 | 安徽蜂献蜂业有限公司 | 一种保健水果蜂蜜膏及其加工方法 |
CN108030081A (zh) * | 2017-12-19 | 2018-05-15 | 安徽蜂献蜂业有限公司 | 一种木瓜养颜蜂蜜膏及其加工方法 |
Non-Patent Citations (2)
Title |
---|
醇沉对纯化金银花中绿原酸工艺的影响;杨海燕等;《中成药》;20060930;第28卷(第9期);第1256-1259页 * |
金银花浸膏的提取工艺研究;杨洪武等;《中华中医药学刊》;20080831;第26卷(第8期);第1828-1830页 * |
Also Published As
Publication number | Publication date |
---|---|
CN108813500A (zh) | 2018-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101695376B (zh) | 预防糖尿病的保健食品 | |
CN103493941B (zh) | 一种减肥保健茶及其制备方法 | |
CN104435775A (zh) | 一种中药保健酒及其制备方法 | |
JP2003192605A (ja) | リパーゼ阻害剤 | |
CN103041118A (zh) | 一种具有降血糖降血脂作用的组合物 | |
CN109730180A (zh) | 一种降血压、降血脂、降血糖组合物及其制备方法和袋泡茶 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN112618691A (zh) | 一种具有补气血功效的中药组合物及其制备方法和应用 | |
CN110327421A (zh) | 一种适合宇航员具有提高精力和协调人体各器官功能的组合物 | |
CN108813501B (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN112167574A (zh) | 一种新鲜龟苓膏及其制备方法 | |
CN102273679A (zh) | 一种饮料的制作方法 | |
CN107751993A (zh) | 一种抗疲劳膏滋及其制备方法 | |
CN103142916B (zh) | 一种预防和治疗老年性痴呆病的药物 | |
KR20120121468A (ko) | 성기능 개선효과를 갖는 무수 유산균발효 건강 기능식품의 제조방법 | |
CN108813500B (zh) | 具有补中益气、养血安神和调节人体机能的养生蜂蜜膏 | |
CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
CN104324329A (zh) | 一种安神补脑的桑葚口服液及其制备方法 | |
JP2004352626A (ja) | 植物由来成分を含有する抗コレステロール剤 | |
KR101479096B1 (ko) | 생약혼합물의 추출물을 함유하는 산전산후부종 예방 또는 개선용 건강기능식품 | |
CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
CN102138593A (zh) | 荷叶消脂健美茶的配方 | |
CN111084878A (zh) | 一种用于肺及呼吸系统疾病的生物医药、医用全营养食品及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Health preserving honey cream with the functions of Tonifying the middle and Supplementing Qi, nourishing blood and calming nerves and regulating human body functions Effective date of registration: 20220601 Granted publication date: 20210921 Pledgee: Zhangshu Shunyin Village Bank Co.,Ltd. Pledgor: JIANGXI TIANYUAN PHARMACEUTICAL CO.,LTD. Registration number: Y2022980006899 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |